Deciphera Pharmaceuticals, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Deciphera Pharmaceuticals, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $1.28 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $1.28M, a 102.20% increase from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $635.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2023-12-31 | $1.28M 10-K · filed 2024-02-07 |
| 2022-12-31 | $635.00K 10-K · filed 2024-02-07 |